Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?
about
Correlates of Protection for M Protein-Based Vaccines against Group A StreptococcusStructure-Informed Design of an Enzymatically Inactive Vaccine Component for Group A StreptococcusMolecular and genomic characterization of pathogenic traits of group A Streptococcus pyogenesUpdated model of group A Streptococcus M proteins based on a comprehensive worldwide study.Rapid Emergence of a New Clone Impacts the Population at Risk and Increases the Incidence of Type emm89 Group A Streptococcus Invasive Disease.An emm5 Group A Streptococcal Outbreak Among Workers in a Factory Manufacturing Telephone Accessories.Convergent synthetic methodology for the construction of self-adjuvanting lipopeptide vaccines using a novel carbohydrate scaffold.Disease manifestations and pathogenic mechanisms of Group A Streptococcus.Seroprevalence of Streptococcal Inhibitor of Complement (SIC) suggests association of streptococcal infection with chronic kidney diseaseStreptococcus pyogenes strains in Sao Paulo, Brazil: molecular characterization as a basis for StreptInCor coverage capacity analysisStreptococcus pyogenes emm Types and Clusters during a 7-Year Period (2007 to 2013) in Pharyngeal and Nonpharyngeal Pediatric Isolates.Activity Regulation by Fibrinogen and Fibrin of Streptokinase from Streptococcus Pyogenes.Group A streptococcal strains isolated in Lao People's Democratic Republic from 2004 to 2013.Detection of group a streptococcal pharyngitis by quantitative PCR.Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci.A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development.The emm-cluster typing system for Group A Streptococcus identifies epidemiologic similarities across the Pacific region.Management of Contacts of Patients With Severe Invasive Group A Streptococcal Infection.Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity.The quest for GAS vaccineAdded value of the emm-cluster typing system to analyze group A Streptococcus epidemiology in high-income settings.Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity.Synthesis, Characterization and Immunological Evaluation of Self-Adjuvanting Group A Streptococcal Vaccine Candidates Bearing Various Lipidic Adjuvanting Moieties.In silico characterisation of the two-component system regulators of Streptococcus pyogenes.
P2860
Q27009175-925AF5C6-DD2B-4DA9-8EED-6E91E17E67DCQ27679389-337F525D-5DF7-4BA4-921D-C67F17EECB04Q28388496-6E52FD2A-FC62-49DE-ABAA-A99697A27F89Q30427910-AC523F56-A1EA-4C46-85B5-F8FBB1091BF7Q33609460-FB0AB920-3772-47C8-90A8-3AE4C53F3752Q33819335-72147F1A-817F-4BED-9BFD-37FEF88B1062Q34083111-A18D1C4E-98E9-409B-9143-2A62A3BA33DAQ34413457-0C2B9743-1F59-4D78-8790-98635E59524CQ34704973-796B84C9-7198-4E66-ABE3-B02908FC3DFEQ35737965-6E5204AC-00C0-4924-9597-FBA3177006FAQ35757601-282A9A44-86C5-40E8-9DB6-A44BC3B64AD8Q36261579-AC90EBFB-D8BC-4E78-AA4E-38619F176483Q36867527-66E79AEB-5D26-490D-97CB-BBF5CD5F90C4Q37014606-03CA964D-A73A-4CA7-8795-1B83F9A07598Q38612165-3AC3682B-97E6-456A-9CB8-34E852D269E1Q39197885-0822FD40-0E4C-4D72-A2D7-FA422C105C3EQ40202353-0CE8C933-7E1A-499B-8655-46C6A11411C4Q40780148-6024F3E5-77E0-41D1-AF31-FC6C8E25EF59Q41588446-072E78BD-FF91-4962-A000-58E2D51178E7Q42551609-3F55A28A-69EA-4C6C-86FC-5FBFBFB1B37DQ42998510-F5C8F7D6-B603-45D9-9107-137FB4692785Q47666939-99C92C3A-020F-40A9-991F-AE0A307027F2Q51200726-22252739-87F3-424F-B0E4-27797DC9D754Q55496682-8AF3F217-9FF8-49D3-A07B-4585B8437FED
P2860
Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differences among group A stre ...... for M protein-based vaccines?
@en
Differences among group A stre ...... for M protein-based vaccines?
@nl
type
label
Differences among group A stre ...... for M protein-based vaccines?
@en
Differences among group A stre ...... for M protein-based vaccines?
@nl
prefLabel
Differences among group A stre ...... for M protein-based vaccines?
@en
Differences among group A stre ...... for M protein-based vaccines?
@nl
P2093
P2860
P356
P1476
Differences among group A stre ...... for M protein-based vaccines?
@en
P2093
David J McMillan
Melina M Georgousakis
Pierre R Smeesters
P2860
P304
P356
10.1586/ERV.09.133
P577
2009-12-01T00:00:00Z